A Study of BXQ-350 in Children and Young Adults With Relapsed Solid Tumors

NCT03967093 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
9
Enrollment
INDUSTRY
Sponsor class

Stopped Bexion will not move forward with the Part 2 expansion portion of the trial in order to focus resources on the further development of BXQ-350 as an earlier treatment measure in the pediatric population.

Conditions

Interventions

Sponsor

Bexion Pharmaceuticals, Inc.

Collaborators